Elekta AB (publ) (OTCMKTS:EKTAY) PT Lowered to SEK 62

Elekta AB (publ) (OTCMKTS:EKTAYGet Rating) had its target price lowered by investment analysts at Morgan Stanley from SEK 63 to SEK 62 in a report released on Thursday, The Fly reports. The firm presently has an “underweight” rating on the stock.

Separately, Citigroup started coverage on shares of Elekta AB (publ) in a report on Monday, December 12th. They issued a “sell” rating on the stock. Four analysts have rated the stock with a sell rating and one has issued a hold rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Reduce” and an average price target of $65.50.

Elekta AB (publ) Trading Up 1.2 %

Shares of Elekta AB (publ) stock opened at $6.63 on Thursday. The firm has a market capitalization of $2.54 billion, a PE ratio of 20.08 and a beta of 1.05. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.08 and a quick ratio of 0.82. The company’s fifty day moving average price is $5.88 and its two-hundred day moving average price is $6.00. Elekta AB has a 52-week low of $4.68 and a 52-week high of $11.39.

Elekta AB (publ) Company Profile

(Get Rating)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology.

See Also

The Fly logo

Analyst Recommendations for Elekta AB (publ) (OTCMKTS:EKTAY)

Receive News & Ratings for Elekta AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elekta AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.